EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serological surveillance on potential Plasmodium vivax exposure risk in a post-elimination setting

Fang Huang, Yanwen Cui, Zhuoying Huang, Siqi Wang, Shigang Li, Xiangrui Guo, Xiang Guo, Zhi-Gui Xia

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1132917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Fang Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunization, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China. Hauptthemen laut MEDLINE: Malaria, Falciparum, Malaria, Vivax, Malaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

China was declared malaria free in June of 2021. In the post-elimination setting, vigilant surveillance is essential to sustain malaria free status. Serological surveillance has been recognized as an efficient tool for assessing the immunity levels and exposure risk in a population. In this study, a cross-sectional serological survey was conducted in Yingjiang County, China, in August–September, 2021. The study sites were villages along the borders with Myanmar, which have no local transmission since the last indigenous case registered in 2016. A total of 923 participants from six villages were enrolled. The majority was aged > 36 years (56.12%) and 12.46% (115/923) participants had experienced malaria infection at least once. A magnetic- bead-based assay was used to test antibodies against Plasmodium vivax antigen PvMSP-1 19 to evaluate the prevalence of antibody positive subjects. A reversible catalytic model was used to assess the risk of exposure. The prevalence of anti-PvMSP-1 19 IgG was 12.84% [95% confidence interval (CI): 9.22%–16.47%], 13.93% (95% CI: 10.11%–17.74%), and 3.57% (95% CI: 1.40%–5.75%) in three different line-of-defense areas, which differed significantly ( P < 0.0001). The prevalence of anti-PvMSP-1 19 IgG increased with age and no statistically significant difference was detected between the sexes. The reversible catalytic model indicated that the seropositive conversion rate and seronegative reversion rate were 0.0042, 0.0034, 0.0032 and 0.0024, 0.0004, 0.0065 in the first-, second-line-of-defense area and total areas, respectively, and the fitted value did not differ significantly from the observed value ( P > 0.1). Although this study found the prevalence of antibody-positive subjects and the seroconversion rate in this post-elimination setting were lower than that in transmission setting, the population still had an exposure risk. Serological surveillance should be considered in post-elimination settings to provide valuable information with which to evaluate the risk of malaria re-establishment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, FalciparumMalaria, VivaxMalariaHumansPlasmodium vivaxPlasmodium falciparumCross-Sectional StudiesSeroepidemiologic StudiesAntibodies, ProtozoanImmunoglobulin G

Stichwörter der Autor:innen

ChinaPlasmodium vivaxanti-PvMSP-1 IgGpost-elimination settingserological surveillance

Substanzen

Antibodies, ProtozoanImmunoglobulin G

Autor:innen und Institutionen

  • Institute of Immunization, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
  • Division of Tuberculosis Control and Prevention, Shanghai Pudong Center for Disease Control and Prevention, Shanghai, China.
  • National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.
  • Department of Malaria, Chinese Center for Tropical Diseases Research, Shanghai, China.
  • NHC Key Laboratory of Parasite and Vector Biology, National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.
  • WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai, China.

Zitieren

APA

Huang, F., Cui, Y., Huang, Z., Wang, S., Li, S., Guo, X., Guo, X., & Xia, Z. G. (2023). Serological surveillance on potential Plasmodium vivax exposure risk in a post-elimination setting. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1132917

Vancouver

Huang F, Cui Y, Huang Z, Wang S, Li S, Guo X, et al. Serological surveillance on potential Plasmodium vivax exposure risk in a post-elimination setting. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1132917

BibTeX
@article{Huang2023,
  author = {Huang, Fang and Cui, Yanwen and Huang, Zhuoying and Wang, Siqi and Li, Shigang and Guo, Xiangrui and Guo, Xiang and Xia, Zhi-Gui},
  title = {Serological surveillance on potential Plasmodium vivax exposure risk in a post-elimination setting},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1132917}
}
Kostenlos starten →